Evidence map›Paper›PMID 42872865›Full record

ArticleCell proliferation2026

MD-1 Deficiency Mitigates Atherosclerosis by Inhibiting NLRP3 Inflammasome Activation via cGAS-STING Dependent Pathway in Macrophages.

Fang Zhao, Zhili Jin, Zhiwei Cai, Quan Zhang, Tao He, Xiangjie Kong, Ming Chen, Zhibing Lu, Xiaorong Hu, Wen-Lin Cheng

Abstract read
In one paragraph

Article in Cell proliferation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fang ZhaoDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.ORCID https://orcid.org/0000-0002-2816-0319
Zhili JinDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.
Zhiwei CaiDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.
Quan ZhangDepartment of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tao HeDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.
Xiangjie KongDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.
Ming ChenDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.
Zhibing LuDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.ORCID https://orcid.org/0000-0002-7950-3465
Xiaorong HuDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.ORCID https://orcid.org/0000-0002-5441-6648
Wen-Lin ChengDepartment of Cardiology, Hubei Provincial Clinical Research Center for Cardiovascular Interventional Diagnosis and Treatment, Zhongnan Hospital, Wuhan University, Wuhan, China.ORCID https://orcid.org/0009-0008-1591-4581

Funding

Translational Medicine and interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University ZNJC202405Yellow Crane of Excellence Program HHYC2019003Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund CXPY2023034
6 · The paper itself

Abstract

MD-1 plays significant roles in various pathological processes closely associated with cardiovascular diseases through its functions in different cell types. However, the critical effects and molecular mechanisms mediated by MD-1 in macrophages involved in the development of atherosclerosis remain elusive. In this study, we observed that the expression of MD-1 was upregulated in atherosclerotic plaques derived from human carotid arteries, as analysed through the Gene Expression Omnibus database. Additionally, MD-1 expression was elevated in the aortas of hyperlipidemic ApoE-deficient mice and in oxidised low-density lipoprotein-stimulated bone marrow-derived macrophages, as demonstrated by RT-PCR and western blot analyses. Furthermore, MD-1 expression exhibited strong co-localisation with macrophages, as confirmed by double immunofluorescence staining. Notably, MD-1

Indexed as

atherosclerosiscGAS‐STINGmacrophage polarisationMD‐1NLRP3 inflammasome

Identifiers

PMID42872865
PMCPMC13664726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.